Patients with advanced dementia should have increased access to comprehensive care wherever they live, including the facilities in which they spend th... More »
PHILADELPHIA – Leuprolide acetate, in combination with an acetylcholinesterase inhibitor, helped to preserve cognitive function in Alzheimer’s disease patients in an exploratory study.
The <a...
PHILADELPHIA – An amyloid PET scan with florbetapir detected which patients with mild cognitive impairment had a high risk for further cognitive dec... More »
AMSTERDAM – The incidence of burning mouth syndrome is considerably lower than previously reported, according to findings from the first population-based study of the disorder.
The age- and...
The risk of substance use and delinquent behavior is higher in teens whose mothers were depressed when their children were aged 6-10 years, a study showed.
“Engagement in risky behaviors, which are...
*Article updated 12/18/14
The massive $1.1 trillion spending bill that was approved by Congress before it left for an extended recess included several provisions aimed at bolstering...
The Food and Drug Administration is warning that the atypical antipsychotic ziprasidone (Geodon) may be associated with a rare but potentially fatal skin reaction.
The agency issued <a...
BERLIN – Chronic use of benzodiazepines by elderly patients is associated with a 43%-51% increased risk of being diagnosed with Alzheimer’s disease 5-10 years later, according to a large case-control...
Mental stress triggered significantly more myocardial ischemia in younger women with stable coronary heart disease than in younger men with CHD, according to a study presented at the American Heart...
BOSTON – The risk for cognitive decline following cancer treatment varies by both cancer and therapy types, and can range from subtle changes to severe deficits, according to a researcher.
Patients...